Cargando…

Correction: Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114914/ https://www.ncbi.nlm.nih.gov/pubmed/30157248 http://dx.doi.org/10.1371/journal.pone.0203499

Ejemplares similares

Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis
por: Singh, Siddharth, et al.
Publicado: (2018)

Correction: Adverse Events of Anti-Tumor Necrosis Factor α Therapy in Ankylosing Spondylitis
por: Tong, Qiang, et al.
Publicado: (2015)

Correction: Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis—A Meta-Analysis
por: Fisher, Anat, et al.
Publicado: (2017)

Correction: Potentiation of tumor necrosis factor-α-induced tumor cell apoptosis by a small molecule inhibitor for anti-apoptotic protein hPEBP4
por: Qiu, Jianming, et al.
Publicado: (2021)

Correction: Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases
Publicado: (2018)

Correction: Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
Publicado: (2020)

Correction: Ablation of Tumor Necrosis Factor Is Associated with Decreased Inflammation and Alterations of the Microbiota in a Mouse Model of Inflammatory Bowel Disease
por: Jones-Hall, Yava L., et al.
Publicado: (2015)

Author Correction: Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
por: Smolarczyk, Ryszard, et al.
Publicado: (2020)

Correction: Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
por: Mączyńska, Justyna, et al.
Publicado: (2022)

Correction: Curcumin Inhibits Glyoxalase 1—A Possible Link to Its Anti-Inflammatory and Anti-Tumor Activity
por: Santel, Thore, et al.
Publicado: (2011)

Correction to: Inhibition of autophagy enhances synergistic effects of Salidroside and anti-tumor agents against colorectal cancer
por: Li, Hai, et al.
Publicado: (2018)

Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
por: Park, Jihye, et al.
Publicado: (2021)

Correction: Surgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer Recurrence
por: Ananth, Abhirami A., et al.
Publicado: (2016)

Correction to: Anti-migraine agents from an immunological point of view
por: Assas, Mushref Bakri
Publicado: (2021)

Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
por: Kang, Eun Ae, et al.
Publicado: (2022)

Correction to: Characterizing the selectivity of ER α-glucosidase inhibitors
Publicado: (2023)

Correction to: Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review
por: Rezk, Mourad F., et al.
Publicado: (2020)

Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
por: Knox, Tessa, et al.
Publicado: (2019)

Correction: Distinct Mechanisms of Inadequate Erythropoiesis Induced by Tumor Necrosis Factor Alpha or Malarial Pigment
por: Lamikanra, Abigail A., et al.
Publicado: (2015)

Correction: Mitochondria Are the Target Organelle of Differentiation-Inducing Factor-3, an Anti-Tumor Agent Isolated from Dictyostelium discoideum
por: Kubohara, Yuzuru, et al.
Publicado: (2013)

Correction: Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin
por: Veloso, Artur, et al.
Publicado: (2013)

Correction: Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents
por: Pasdar, Elham Alizadeh, et al.
Publicado: (2016)

Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease
por: Hiraoka, Sakiko, et al.
Publicado: (2018)

Disaccharide Esters Screened for Inhibition of Tumor Necrosis Factor‐α Release Are New Anti‐cancer Agents
por: Okabe, Sachiko, et al.
Publicado: (1999)

Correction: Anti-Angiogenic and Anti-Inflammatory Properties of Kahweol, a Coffee Diterpene
por: Cárdenas, Casimiro, et al.
Publicado: (2011)

Correction: Cytokines and cytokine receptors as targets of immune-mediated inflammatory diseases—RA as a role model
por: Takeuchi, Tsutomu
Publicado: (2022)

Correction: Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
Publicado: (2017)

Tumor Necrosis Factor-α and Interleukin-6: Potential Interorgan Inflammatory Mediators Contributing to Destructive Periodontal Disease in Obesity or Metabolic Syndrome
por: Khosravi, Roozbeh, et al.
Publicado: (2013)

Correction to: A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity
por: Danaher, Patrick, et al.
Publicado: (2019)

Factors Associated with the Immunogenicity of Anti-Tumor Necrosis Factor Agents in Pediatric Patients with Inflammatory Bowel Disease
por: Kim, Ju Young, et al.
Publicado: (2021)

Correction to: Aconitum lycoctonum L. (Ranunculaceae) mediated biogenic synthesis of silver nanoparticles as potential antioxidant, anti-infammatory, antimicrobial and antidiabetic agents
por: Khan, Zia ur Rehman, et al.
Publicado: (2023)

Correction to: Selective inhibition of integrin αvβ6 leads to rapid induction of urinary bladder tumors in cynomolgus macaques
Publicado: (2023)

Author Correction: Fcmr regulates mononuclear phagocyte control of anti-tumor immunity
por: Kubli, Shawn P., et al.
Publicado: (2019)

Rare and Serious Adverse Effects of Anti-Tumor Necrosis Factor-Alpha (TNF-α) Agents in Crohn’s Disease
por: Kim, Sun, et al.
Publicado: (2021)

Correction: Targeting Vascular NADPH Oxidase 1 Blocks Tumor Angiogenesis through a PPARα Mediated Mechanism
por: Garrido-Urbani, Sarah, et al.
Publicado: (2011)

Correction: A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agent
Publicado: (2017)

Correction to: Fat necrosis in the breast: a systematic review of clinical
por: Vasei, Narges, et al.
Publicado: (2019)

Correction to: FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway
por: Sun, Cheng-Cao, et al.
Publicado: (2021)

Correction: FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway
por: Sun, Cheng-Cao, et al.
Publicado: (2023)

Correction: Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting
por: Kim, Ji-Young, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dvkvs7vfqq6vn1h3jj0u4uanjt